Revela Health
PrivateLast Round
Pre Seed
Dec 4, 2025
Total Funding Raised
$550,000
Company Overview
Revela Health operates in Healthcare & Life Sciences and is based in Newcastle upon Tyne. Its latest recorded funding round was a Pre Seed round in December 2025.
Revela Health is a healthcare technology company developing diagnostic-support software for the non-invasive detection of endometriosis.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revela Health Comparables
Compare Revela Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Scanvio Medical | 86% | |
| BioticsAI | 65% | |
| EndoSure, Inc. | 63% |
For institutional investors. Book with your work email.
Revela Health Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Revela Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alma Angels | Pre Seed |
| Sixth Wave Ventures | Pre Seed |
| Leeds Angels | Pre Seed |
| PXN Ventures | Pre Seed |
| Mint Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors grew 437% MoM, reaching 2.3K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 7, 2026
On Oct 7th '26 in the United Kingdom, Revela Health Limited is developing software that analyses ultrasound scans to identify potential signs of endometriosis earlier in the diagnostic pathway, with support from Arrow and Durham University.
- attends_eventOct 7, 2026
Revela Health Limited receives the Start-Up of the year Award at the Bionow Awards in Mar '26.
- is_developingOct 7, 2026
Revela Health Limited is accelerating development of an AI-powered platform that analyzes ultrasound scans to identify potential signs of endometriosis earlier in the diagnostic pathway, with support from the Arrow innovation programme and Durham University.
For institutional investors. Book with your work email.
Revela Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Revela Health's valuation, stock price, and market status.
Is Revela Health a public or private company?
Revela Health is a private company.
What is the current stock price of Revela Health?
Revela Health is a private company, so its shares have no public market price. Caplight tracks Revela Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Revela Health worth (valuation)?
Valuation information for Revela Health is not publicly available.
Can I buy Revela Health stock?
Revela Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Revela Health's last funding round?
Revela Health's most recent funding round was Pre Seed on December 4, 2025.
Who are the main investors in Revela Health?
Key investors in Revela Health include PXN Ventures.
Will Revela Health IPO soon?
No public IPO plans have been announced for Revela Health.
How can I track Revela Health secondary market activity?
Caplight tracks bids, offers, and trades in Revela Health's shares on secondary markets.